These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 18027457)

  • 1. [Treatment modification in multiple sclerosis: classifications, alternatives, and the outcomes].
    Cendrowski W
    Neurol Neurochir Pol; 2007; 41(4):365-8. PubMed ID: 18027457
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy of multiple sclerosis--current practice and future directions.
    Tullman MJ; Lublin FD; Miller AE
    J Rehabil Res Dev; 2002; 39(2):273-85. PubMed ID: 12051470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multiple sclerosis--difficult answers to easy questions].
    Bartosik-Psujek H; Stelmasiak Z
    Neurol Neurochir Pol; 2006; 40(5):441-5. PubMed ID: 17103358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [What's new in multiple sclerosis therapy?].
    Vaney C; Derfuss T
    Rev Med Suisse; 2013 Jan; 9(371):285-7. PubMed ID: 23451607
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunologic therapy of multiple sclerosis.
    Arnason BG
    Annu Rev Med; 1999; 50():291-302. PubMed ID: 10073279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-modifying drugs for the early treatment of multiple sclerosis.
    Flachenecker P
    Expert Rev Neurother; 2004 May; 4(3):455-63. PubMed ID: 15853542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A practical guide to pediatric multiple sclerosis.
    Huppke P; Gärtner J
    Neuropediatrics; 2010 Aug; 41(4):157-62. PubMed ID: 21086219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The challenge of managing patients with multiple sclerosis.
    MacLean R
    Nurs Times; 2004 Jan 27-Feb 2; 100(4):42-4. PubMed ID: 14974264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostics and drug therapy of multiple sclerosis].
    Suomen Neurologinen Yhdistys ry
    Duodecim; 2002; 118(13):1411-23. PubMed ID: 12239889
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunomodulatory therapy in multiple sclerosis].
    Csépány T; Bereczki D
    Ideggyogy Sz; 2004 Nov; 57(11-12):401-16. PubMed ID: 15662768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new era of multiple sclerosis therapy.
    Olsson T
    J Intern Med; 2014 Apr; 275(4):382-6. PubMed ID: 24433367
    [No Abstract]   [Full Text] [Related]  

  • 12. [Multiple sclerosis. Treatment: hopes and realities].
    Lubetzki C
    Presse Med; 1997 Oct; 26(32):1543-6. PubMed ID: 9435838
    [No Abstract]   [Full Text] [Related]  

  • 13. [Multiple sclerosis: can therapy delay ongoing disability?].
    Havla J; Pellkofer HL; Hohlfeld R; Kümpfel T
    MMW Fortschr Med; 2011 Apr; 153(14):63-6. PubMed ID: 21966873
    [No Abstract]   [Full Text] [Related]  

  • 14. Approaches to neuroprotective strategies in multiple sclerosis.
    Tselis A; Khan OA; Lisak RP
    Expert Opin Pharmacother; 2010 Dec; 11(17):2869-78. PubMed ID: 20687779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease modification in multiple sclerosis.
    Sheerani M
    J Pak Med Assoc; 2003 Dec; 53(12):612-5. PubMed ID: 14765944
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination therapy for multiple sclerosis: the treatment strategy of the future?
    Weinstock-Guttman B; Bakshi R
    CNS Drugs; 2004; 18(12):777-92. PubMed ID: 15377168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early immunotherapy in MS reduces the risk of later disability. The secondary progressive course is delayed, according to a study with virtual placebo].
    Tedeholm H; Skoog B; Hillert J; Runmarker B; Stawiarz L; Oluf A
    Lakartidningen; 2007 May 30-Jun 3; 104(22):1684-8. PubMed ID: 17601317
    [No Abstract]   [Full Text] [Related]  

  • 18. Secondary progressive multiple sclerosis: current knowledge and future challenges.
    Rovaris M; Confavreux C; Furlan R; Kappos L; Comi G; Filippi M
    Lancet Neurol; 2006 Apr; 5(4):343-54. PubMed ID: 16545751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Not every patient with multiple sclerosis should be treated at time of diagnosis.
    Pittock SJ; Weinshenker BG; Noseworthy JH; Lucchinetti CF; Keegan M; Wingerchuk DM; Carter J; Shuster E; Rodriguez M
    Arch Neurol; 2006 Apr; 63(4):611-4. PubMed ID: 16606780
    [No Abstract]   [Full Text] [Related]  

  • 20. Update on MS treatment.
    Ryan M
    J Am Pharm Assoc (Wash); 1996 Jul; NS36(7):419-20. PubMed ID: 8840740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.